CasNo.186826-86-8,Top Quality Raw Material CAS 186826-86-8 Moxifloxacin Hydrochloride Moxifloxacin Hcl,Moxifloxacin hydrochloride(186826-86-8) Suppliers

0	Negotiable

Min.Order :0
Purity: 99%

Keywords

Moxifloxacin Hcl Moxifloxacin Hydrochloride 186826-86-8

Quick Details

Appearance:White to off-white powder
Application:Mainly use in pharmaceutical intermediates/medical intermediate/ research purpose
PackAge:Aluminum foil bag,fluorinated bottles,carboard drums or as your special request.
ProductionCapacity:
Storage:Store in cool & dry place. Keep away from strong light Shelf Life2 years when properly stored.
Transportation:1) Door to Door Service by DHL/FEDEX/EMS/TNT for package under 45kgs, about 3~7 days delivery. 2) Port to Port Service by Air for package more than 45kgs, about 3~7 days delivery. 3) Port to Port...

Superiority:

1) Provide costomers with "one-stop"packaging service,from research,development,production,export and so on.
2) We have our own R&D and production base,equipped with advanced production equipment and precision testing the Unitef States Pharmacopoeia(USP),the Britis Pharmacopoeia(EP) and other international advanced standards.All products are through the KOSGER,HALAL certification,the ISO quality management system certification and the HACCP certification.
3) More than 12 years of export experience.
4)Competitive price in China market.

Details:

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic, It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.
Moxifloxacin hydrochloride is used to treat patients suffering from upper respiratory tract infections and lower respiratory tract of adults (≥ 18 years), such as: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, and skin and soft tissue infections.